Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 431 entries
Sorted by: Best Match Show Resources per page
Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population.

Annals of gastroenterology

Jiang Z, Butler-Bowen H, Rodriguez T, Garcon MC, Smith MH, Relias V, Saif MW.
PMID: 27708523
Ann Gastroenterol. 2016 Oct-Dec;29(4):536-543. doi: 10.20524/aog.2016.0065. Epub 2016 Jun 16.

BACKGROUND: Fatigue is a common but devastating symptom for advanced pancreatic cancer (APC) patients. To date, no proven treatment exists. Methylphenidate (MPH) showed inconsistent results in treating other cancer related fatigue. We performed a retrospective study to assess MPH...

Cite
Jiang Z, Butler-Bowen H, Rodriguez T, et al. Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population. Ann Gastroenterol. 2016;29(4):536-543doi: 10.20524/aog.2016.0065.
Jiang, Z., Butler-Bowen, H., Rodriguez, T., Garcon, M. C., Smith, M. H., Relias, V., & Saif, M. W. (2016). Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population. Annals of gastroenterology, 29(4), 536-543. https://doi.org/10.20524/aog.2016.0065
Jiang, Zhenyang, et al. "Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population." Annals of gastroenterology vol. 29,4 (2016): 536-543. doi: https://doi.org/10.20524/aog.2016.0065
Jiang Z, Butler-Bowen H, Rodriguez T, Garcon MC, Smith MH, Relias V, Saif MW. Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population. Ann Gastroenterol. 2016 Oct-Dec;29(4):536-543. doi: 10.20524/aog.2016.0065. Epub 2016 Jun 16. PMID: 27708523; PMCID: PMC5049564.
Copy Download .nbib Format: NLM
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors.

OncoTargets and therapy

Kotteas EA, Syrigos KN, Saif MW.
PMID: 26929640
Onco Targets Ther. 2016 Feb 09;9:699-704. doi: 10.2147/OTT.S72155. eCollection 2016.

Neuroendocrine tumors are a rare and heterogeneous group of tumors with a variety of primary origins and variable aggressiveness. Platinum-based chemotherapy has been the cornerstone of treatment for the poorly differentiated tumors. However, well-differentiated neuroendocrine tumors are quite chemoresistant...

Cite
Kotteas EA, Syrigos KN, Saif MW. Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors. Onco Targets Ther. 2016;9:699-704doi: 10.2147/OTT.S72155.
Kotteas, E. A., Syrigos, K. N., & Saif, M. W. (2016). Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors. OncoTargets and therapy, 9699-704. https://doi.org/10.2147/OTT.S72155
Kotteas, Elias A, et al. "Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors." OncoTargets and therapy vol. 9 (2016): 699-704. doi: https://doi.org/10.2147/OTT.S72155
Kotteas EA, Syrigos KN, Saif MW. Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors. Onco Targets Ther. 2016 Feb 09;9:699-704. doi: 10.2147/OTT.S72155. eCollection 2016. PMID: 26929640; PMCID: PMC4755420.
Copy Download .nbib Format: NLM
Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.

Nature genetics

Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, Ntalla I, Surendran P, Liu C, Cook JP, Kraja AT, Drenos F, Loh M, Verweij N, Marten J, Karaman I, Segura Lepe MP, O'Reilly PF, Knight J, Snieder H, Kato N, He J, Tai ES, Said MA, Porteous D, Alver M, Poulter N, Farrall M, Gansevoort RT, Padmanabhan S, Mägi R, Stanton A, Connell J, Bakker SJL, Metspalu A, Shields DC, Thom S, Brown M, Sever P, Esko T, Hayward C, van der Harst P, Saleheen D, Chowdhury R, Chambers JC, Chasman DI, Chakravarti A, Newton-Cheh C, Lindgren CM, Levy D, Kooner JS, Keavney B, Tomaszewski M, Samani NJ, Howson JMM, Tobin MD, Munroe PB, Ehret GB, Wain LV, Barnes MR, Tzoulaki I, Caulfield MJ, Elliott P.
PMID: 28951623
Nat Genet. 2017 Sep 27;49(10):1558. doi: 10.1038/ng1017-1558a.

No abstract available.

Cite
Warren HR, Evangelou E, Cabrera CP, et al. Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49(10):1558doi: 10.1038/ng1017-1558a.
Warren, H. R., Evangelou, E., Cabrera, C. P., Gao, H., Ren, M., Mifsud, B., Ntalla, I., Surendran, P., Liu, C., Cook, J. P., Kraja, A. T., Drenos, F., Loh, M., Verweij, N., Marten, J., Karaman, I., Segura Lepe, M. P., O'Reilly, P. F., Knight, J., Snieder, H., Kato, N., He, J., Tai, E. S., Said, M. A., Porteous, D., Alver, M., Poulter, N., Farrall, M., Gansevoort, R. T., Padmanabhan, S., Mägi, R., Stanton, A., Connell, J., Bakker, S. J. L., Metspalu, A., Shields, D. C., Thom, S., Brown, M., Sever, P., Esko, T., Hayward, C., van der Harst, P., Saleheen, D., Chowdhury, R., Chambers, J. C., Chasman, D. I., Chakravarti, A., Newton-Cheh, C., Lindgren, C. M., Levy, D., Kooner, J. S., Keavney, B., Tomaszewski, M., Samani, N. J., Howson, J. M. M., Tobin, M. D., Munroe, P. B., Ehret, G. B., Wain, L. V., Barnes, M. R., Tzoulaki, I., Caulfield, M. J., Elliott, P. (2017). Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nature genetics, 49(10), 1558. https://doi.org/10.1038/ng1017-1558a
Warren, Helen R, et al. "Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk." Nature genetics vol. 49,10 (2017): 1558. doi: https://doi.org/10.1038/ng1017-1558a
Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, Ntalla I, Surendran P, Liu C, Cook JP, Kraja AT, Drenos F, Loh M, Verweij N, Marten J, Karaman I, Segura Lepe MP, O'Reilly PF, Knight J, Snieder H, Kato N, He J, Tai ES, Said MA, Porteous D, Alver M, Poulter N, Farrall M, Gansevoort RT, Padmanabhan S, Mägi R, Stanton A, Connell J, Bakker SJL, Metspalu A, Shields DC, Thom S, Brown M, Sever P, Esko T, Hayward C, van der Harst P, Saleheen D, Chowdhury R, Chambers JC, Chasman DI, Chakravarti A, Newton-Cheh C, Lindgren CM, Levy D, Kooner JS, Keavney B, Tomaszewski M, Samani NJ, Howson JMM, Tobin MD, Munroe PB, Ehret GB, Wain LV, Barnes MR, Tzoulaki I, Caulfield MJ, Elliott P. Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017 Sep 27;49(10):1558. doi: 10.1038/ng1017-1558a. PMID: 28951623.
Copy Download .nbib Format: NLM
Drug metabolism and pancreatic cancer.

Annals of gastroenterology

Flores JP, Diasio RB, Saif MW.
PMID: 28042238
Ann Gastroenterol. 2017;30(1):54-61. doi: 10.20524/aog.2016.0074. Epub 2016 Jul 21.

Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient's individual cancer. Potentially, therapy can be targeted at individuals who would most likely have...

Cite
Flores JP, Diasio RB, Saif MW. Drug metabolism and pancreatic cancer. Ann Gastroenterol. 2016;30(1):54-61doi: 10.20524/aog.2016.0074.
Flores, J. P., Diasio, R. B., & Saif, M. W. (2017). Drug metabolism and pancreatic cancer. Annals of gastroenterology, 30(1), 54-61. https://doi.org/10.20524/aog.2016.0074
Flores, John Paul E, et al. "Drug metabolism and pancreatic cancer." Annals of gastroenterology vol. 30,1 (2017): 54-61. doi: https://doi.org/10.20524/aog.2016.0074
Flores JP, Diasio RB, Saif MW. Drug metabolism and pancreatic cancer. Ann Gastroenterol. 2017;30(1):54-61. doi: 10.20524/aog.2016.0074. Epub 2016 Jul 21. PMID: 28042238; PMCID: PMC5198247.
Copy Download .nbib Format: NLM
Stauffer's Syndrome in Pancreatic Cancer: First Case Report.

Cureus

Harris D, Saif MW.
PMID: 28611937
Cureus. 2017 May 08;9(5):e1230. doi: 10.7759/cureus.1230.

Stauffer's syndrome is a rare paraneoplastic syndrome classically associated with renal cell carcinoma. It presents as abnormal hepatic panel in the absence of hepatic disease, which improves with treatment of the cancer and worsens with recurrence. Here, we describe...

Cite
Harris D, Saif MW. Stauffer's Syndrome in Pancreatic Cancer: First Case Report. Cureus. 2017;9(5):e1230doi: 10.7759/cureus.1230.
Harris, D., & Saif, M. W. (2017). Stauffer's Syndrome in Pancreatic Cancer: First Case Report. Cureus, 9(5), e1230. https://doi.org/10.7759/cureus.1230
Harris, David, and Saif, Muhammad W. "Stauffer's Syndrome in Pancreatic Cancer: First Case Report." Cureus vol. 9,5 (2017): e1230. doi: https://doi.org/10.7759/cureus.1230
Harris D, Saif MW. Stauffer's Syndrome in Pancreatic Cancer: First Case Report. Cureus. 2017 May 08;9(5):e1230. doi: 10.7759/cureus.1230. PMID: 28611937; PMCID: PMC5464792.
Copy Download .nbib Format: NLM
Epidemiology of active tuberculosis in lung cancer patients: a systematic review.

The clinical respiratory journal

Christopoulos A, Saif MW, Sarris EG, Syrigos KN.
PMID: 24345074
Clin Respir J. 2014 Oct;8(4):375-81. doi: 10.1111/crj.12094. Epub 2014 Mar 05.

OBJECTIVES: The aim of this review article is to evaluate the available literature concerning the prevalence of active tuberculosis in lung cancer patients.DATA SOURCE: MEDLINE, PubMed, EMBASE and Medscape databases were searched for studies with quantitative data on the...

Cite
Christopoulos A, Saif MW, Sarris EG, et al. Epidemiology of active tuberculosis in lung cancer patients: a systematic review. Clin Respir J. 2014;8(4):375-81doi: 10.1111/crj.12094.
Christopoulos, A., Saif, M. W., Sarris, E. G., & Syrigos, K. N. (2014). Epidemiology of active tuberculosis in lung cancer patients: a systematic review. The clinical respiratory journal, 8(4), 375-81. https://doi.org/10.1111/crj.12094
Christopoulos, Antonis, et al. "Epidemiology of active tuberculosis in lung cancer patients: a systematic review." The clinical respiratory journal vol. 8,4 (2014): 375-81. doi: https://doi.org/10.1111/crj.12094
Christopoulos A, Saif MW, Sarris EG, Syrigos KN. Epidemiology of active tuberculosis in lung cancer patients: a systematic review. Clin Respir J. 2014 Oct;8(4):375-81. doi: 10.1111/crj.12094. Epub 2014 Mar 05. PMID: 24345074.
Copy Download .nbib Format: NLM
Unraveling Aspects of Bacillus amyloliquefaciens Mediated Enhanced Production of Rice under Biotic Stress of Rhizoctonia solani.

Frontiers in plant science

Srivastava S, Bist V, Srivastava S, Singh PC, Trivedi PK, Asif MH, Chauhan PS, Nautiyal CS.
PMID: 27200058
Front Plant Sci. 2016 May 06;7:587. doi: 10.3389/fpls.2016.00587. eCollection 2016.

Rhizoctonia solani is a necrotrophic fungi causing sheath blight in rice leading to substantial loss in yield. Excessive and persistent use of preventive chemicals raises human health and environment safety concerns. As an alternative, use of biocontrol agents is...

Cite
Srivastava S, Bist V, Srivastava S, et al. Unraveling Aspects of Bacillus amyloliquefaciens Mediated Enhanced Production of Rice under Biotic Stress of Rhizoctonia solani. Front Plant Sci. 2016;7:587doi: 10.3389/fpls.2016.00587.
Srivastava, S., Bist, V., Srivastava, S., Singh, P. C., Trivedi, P. K., Asif, M. H., Chauhan, P. S., & Nautiyal, C. S. (2016). Unraveling Aspects of Bacillus amyloliquefaciens Mediated Enhanced Production of Rice under Biotic Stress of Rhizoctonia solani. Frontiers in plant science, 7587. https://doi.org/10.3389/fpls.2016.00587
Srivastava, Suchi, et al. "Unraveling Aspects of Bacillus amyloliquefaciens Mediated Enhanced Production of Rice under Biotic Stress of Rhizoctonia solani." Frontiers in plant science vol. 7 (2016): 587. doi: https://doi.org/10.3389/fpls.2016.00587
Srivastava S, Bist V, Srivastava S, Singh PC, Trivedi PK, Asif MH, Chauhan PS, Nautiyal CS. Unraveling Aspects of Bacillus amyloliquefaciens Mediated Enhanced Production of Rice under Biotic Stress of Rhizoctonia solani. Front Plant Sci. 2016 May 06;7:587. doi: 10.3389/fpls.2016.00587. eCollection 2016. PMID: 27200058; PMCID: PMC4858605.
Copy Download .nbib Format: NLM
Computed tomography virtual cystoscopy for follow-up of patients with superficial bladder tumours in comparison to conventional cystoscopy: An exploratory study.

Arab journal of urology

Elawady H, Mahmoud MA, Mostafa DM, Abdelmaksoud A, Safa MW, Elia RZ.
PMID: 27547459
Arab J Urol. 2016 Jul 25;14(3):192-7. doi: 10.1016/j.aju.2016.06.003. eCollection 2016 Sep.

OBJECTIVE: To evaluate and analyse the efficacy of computed tomography (CT) virtual cystoscopy in comparison to conventional cystoscopy for the follow-up of patients with non-muscle-invasive bladder cancer.PATIENTS AND METHODS: The study was done over 3 years, from April 2010...

Cite
Elawady H, Mahmoud MA, Mostafa DM, et al. Computed tomography virtual cystoscopy for follow-up of patients with superficial bladder tumours in comparison to conventional cystoscopy: An exploratory study. Arab J Urol. 2016;14(3):192-7doi: 10.1016/j.aju.2016.06.003.
Elawady, H., Mahmoud, M. A., Mostafa, D. M., Abdelmaksoud, A., Safa, M. W., & Elia, R. Z. (2016). Computed tomography virtual cystoscopy for follow-up of patients with superficial bladder tumours in comparison to conventional cystoscopy: An exploratory study. Arab journal of urology, 14(3), 192-7. https://doi.org/10.1016/j.aju.2016.06.003
Elawady, Hossam, et al. "Computed tomography virtual cystoscopy for follow-up of patients with superficial bladder tumours in comparison to conventional cystoscopy: An exploratory study." Arab journal of urology vol. 14,3 (2016): 192-7. doi: https://doi.org/10.1016/j.aju.2016.06.003
Elawady H, Mahmoud MA, Mostafa DM, Abdelmaksoud A, Safa MW, Elia RZ. Computed tomography virtual cystoscopy for follow-up of patients with superficial bladder tumours in comparison to conventional cystoscopy: An exploratory study. Arab J Urol. 2016 Jul 25;14(3):192-7. doi: 10.1016/j.aju.2016.06.003. eCollection 2016 Sep. PMID: 27547459; PMCID: PMC4983164.
Copy Download .nbib Format: NLM
Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story.

Cureus

Saif MW, Vethody C.
PMID: 27446766
Cureus. 2016 Jun 19;8(6):e646. doi: 10.7759/cureus.646.

Neuroendocrine carcinomas (NECs) of the esophagus are very rare. The majority of the patients with NECs present with metastasis. Paraneoplastic syndromes, such as syndrome of inappropriate secretion of anti-diuretic hormone and watery diarrhea-hypokalemia-achlorhydria syndrome, have been reported in previous...

Cite
Saif MW, Vethody C. Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story. Cureus. 2016;8(6):e646doi: 10.7759/cureus.646.
Saif, M. W., & Vethody, C. (2016). Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story. Cureus, 8(6), e646. https://doi.org/10.7759/cureus.646
Saif, Muhammad W, and Vethody, Chandra. "Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story." Cureus vol. 8,6 (2016): e646. doi: https://doi.org/10.7759/cureus.646
Saif MW, Vethody C. Poorly Differentiated Neuroendocrine Tumor of the Esophagus with Hypertrophic Osteoarthropathy and Brain Metastasis: A Success Story. Cureus. 2016 Jun 19;8(6):e646. doi: 10.7759/cureus.646. PMID: 27446766; PMCID: PMC4954639.
Copy Download .nbib Format: NLM
Pancreatic tuberculosis or autoimmune pancreatitis.

Case reports in medicine

Salahuddin A, Saif MW.
PMID: 24839445
Case Rep Med. 2014;2014:410142. doi: 10.1155/2014/410142. Epub 2014 Apr 15.

Introduction. Isolated pancreatic and peripancreatic tuberculosis is a challenging diagnosis due to its rarity and variable presentation. Pancreatic tuberculosis can mimic pancreatic carcinoma. Similarly, autoimmune pancreatitis can appear as a focal lesion resembling pancreatic malignancy. Endoscopic ultrasound-guided fine needle...

Cite
Salahuddin A, Saif MW. Pancreatic tuberculosis or autoimmune pancreatitis. Case Rep Med. 2014;2014:410142doi: 10.1155/2014/410142.
Salahuddin, A., & Saif, M. W. (2014). Pancreatic tuberculosis or autoimmune pancreatitis. Case reports in medicine, 2014410142. https://doi.org/10.1155/2014/410142
Salahuddin, Ayesha, and Saif, Muhammad Wasif. "Pancreatic tuberculosis or autoimmune pancreatitis." Case reports in medicine vol. 2014 (2014): 410142. doi: https://doi.org/10.1155/2014/410142
Salahuddin A, Saif MW. Pancreatic tuberculosis or autoimmune pancreatitis. Case Rep Med. 2014;2014:410142. doi: 10.1155/2014/410142. Epub 2014 Apr 15. PMID: 24839445; PMCID: PMC4009261.
Copy Download .nbib Format: NLM
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma.

Oncology letters

Saif MW, Ledbetter L, Kaley K, Garcon MC, Rodriguez T, Syrigos KN.
PMID: 25120712
Oncol Lett. 2014 Sep;8(3):1302-1306. doi: 10.3892/ol.2014.2238. Epub 2014 Jun 11.

Therapeutic options for locally advanced pancreatic cancer (LAPC) include concurrent chemoradiation, induction chemotherapy followed by chemoradiation or systemic therapy alone. The original Gastro-Intestinal Study Group and Eastern Cooperative Oncology Group studies defined fluorouracil (5-FU) with concurrent radiation therapy followed...

Cite
Saif MW, Ledbetter L, Kaley K, et al. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncol Lett. 2014;8(3):1302-1306doi: 10.3892/ol.2014.2238.
Saif, M. W., Ledbetter, L., Kaley, K., Garcon, M. C., Rodriguez, T., & Syrigos, K. N. (2014). Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncology letters, 8(3), 1302-1306. https://doi.org/10.3892/ol.2014.2238
Saif, Muhammad Wasif, et al. "Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma." Oncology letters vol. 8,3 (2014): 1302-1306. doi: https://doi.org/10.3892/ol.2014.2238
Saif MW, Ledbetter L, Kaley K, Garcon MC, Rodriguez T, Syrigos KN. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncol Lett. 2014 Sep;8(3):1302-1306. doi: 10.3892/ol.2014.2238. Epub 2014 Jun 11. PMID: 25120712; PMCID: PMC4114599.
Copy Download .nbib Format: NLM
Dinuclear and Tetranuclear Cages of Oxodiphenylantimony Phosphinates: Synthesis and Structures.

Inorganic chemistry

Said MA, Kumara Swamy KC, Poojary DM, Clearfield A, Veith M, Huch V.
PMID: 11666523
Inorg Chem. 1996 May 22;35(11):3235-3241. doi: 10.1021/ic950713w.

The novel dimeric compounds [Ph(2)Sb(O(2)PR(2))O](2).2CH(2)Cl(2) [R = cycl-C(6)H(11) (2) and cycl-C(8)H(15) (3)] have been synthesized by reacting diphenylantimony trichloride (1) with 3 mol equiv of silver acetate followed by 1 mol equiv of the phosphinic acid. By the same...

Cite
Said MA, Kumara Swamy KC, Poojary DM, et al. Dinuclear and Tetranuclear Cages of Oxodiphenylantimony Phosphinates: Synthesis and Structures. Inorg Chem. 1996;35(11):3235-3241doi: 10.1021/ic950713w.
Said, M. A., Kumara Swamy, K. C., Poojary, D. M., Clearfield, A., Veith, M., & Huch, V. (1996). Dinuclear and Tetranuclear Cages of Oxodiphenylantimony Phosphinates: Synthesis and Structures. Inorganic chemistry, 35(11), 3235-3241. https://doi.org/10.1021/ic950713w
Said, Musa A., et al. "Dinuclear and Tetranuclear Cages of Oxodiphenylantimony Phosphinates: Synthesis and Structures." Inorganic chemistry vol. 35,11 (1996): 3235-3241. doi: https://doi.org/10.1021/ic950713w
Said MA, Kumara Swamy KC, Poojary DM, Clearfield A, Veith M, Huch V. Dinuclear and Tetranuclear Cages of Oxodiphenylantimony Phosphinates: Synthesis and Structures. Inorg Chem. 1996 May 22;35(11):3235-3241. doi: 10.1021/ic950713w. PMID: 11666523.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 431 entries